Trialing a novel cancer treatment

15 July 2019

Two years after the untimely loss of Lea, the generosity of her family, friends and the community has made an incredible difference to the Fahrer laboratory.

Thanks to the generous support of donors to the Lea Chapuis Memorial Fund, Associate Professor Aude Fahrer and her small team from the Fahrer Group at ANU are trialling a novel cancer treatment.

The treatment involves injecting a slow-release bacterial preparation as an immune stimulant directly into a cancer tumour.

Lea was the Principal of Yarralumla Primary School, a close family friend of Aude and a cancer patient

Lea Chapuis
Lea Chapuis

"Lea followed my research for many years and had volunteered to take part in a clinical trial. Sadly, she just missed out as she got too sick. One of her final wishes was that people would make donations to the Fund in lieu of flowers at her funeral," says Aude.

Two years after the untimely loss of Lea, the generosity of her family, friends and the community has made an incredible difference to the Fahrer laboratory.

"It has kept our research going and it's supported some brilliant young PhD students," says Aude.

"One of the real benefits is that the treatment is so inexpensive and simple that it can be used everywhere in the world. It also has few side effects, which is incredible compared to the horrible side effects of chemotherapy."

Aude is immensely grateful for the difference that donors to Lea's Fund have made to her team's research, saying that the Fund will continue to support improving a cheap, simple and potentially life-saving cancer treatment.

Page owner: Philanthropy